Showing results (461-470 of 579) with videos related to
Sort By:
Pageof 58
Neuropediatrics|December 19, 2003
Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 KK Harzer, A Rolfs, P Bauer, et al.Nederlands Tijdschrift Voor Geneeskunde|September 24, 2008
[Recurrence of Clostridium difficile-associated diarrhoea prevented by the administration of a whey concentrate from specifically immunised cows; prospective study]M P Bauer, S C Numan-Ruberg, O W Bredewold, et al.Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|January 19, 2018
A Validation Argument for a Simulation-Based Training Course Centered on Assessment, Recognition, and Early Management of Pediatric SepsisGary L Geis, Derek S Wheeler, Amy Bunger, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2009
Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegiaR Schüle, N Schlipf, M Synofzik, et al.The Journal of Clinical Investigation|May 4, 2006
Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vesselsJun Yu, Sonia Bergaya, Takahisa Murata, et al.Hippocampus|September 5, 2022
Glucagon-like peptide-1 receptor differentially controls mossy cell activity across the dentate gyrus longitudinal axisAlex Steiner, Benjamin M Owen, James P Bauer, et al.Diabetes Care|March 1, 1997
Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic controlR Merio, A Festa, H Bergmann, et al.Neurology|April 10, 2009
Autosomal dominant spastic paraplegia with peripheral neuropathy maps to chr12q23-24R Schüle, M Bonin, A Dürr, et al.The American Journal of Clinical Nutrition|August 19, 2011
Long-term effects of hydrolyzed protein infant formulas on growth--extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) studyPeter Rzehak, Stefanie Sausenthaler, Sibylle Koletzko, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.Pageof 58